Nilotinib intermediate 641569-94-0 CAS NO.641569-94-0
- FOB Price: USD: 400.00-400.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,Other
- Available Specifications:
99%(500-1000)Metric Ton
- Product Details
Keywords
- 641569-94-0
- 641569-94-0
- 641569-94-0
Quick Details
- ProName: Nilotinib intermediate 641569-94-0
- CasNo: 641569-94-0
- Molecular Formula: C17H14N4O2
- Appearance: white powder
- Application: as Nilotinib intermediate
- DeliveryTime: in 7 days
- PackAge: 1KG/bag, 25KG/drum
- Port: Shanghai/beijing/Tianjin
- ProductionCapacity: 10 Metric Ton/Year
- Purity: 99%
- Storage: Room temperature
- Transportation: Regular transportation
- LimitNum: 1 Kilogram
- Moisture Content: 0.5%
- Impurity: 0.1%
Superiority
Why is SINOWAY:
1) Specialized in pharmaceutical and healthcare industrial for 34 years.
2) ISO 9001:2015 & SGS audited supplier .
3) Accept various payment terms : T.T 30-60 days.
4) We have warehouse in USA with quickly shipment .
5) We can do different terms of FOB ,CIF/CIP ,DDP ...
Why choose us
1. best quality in your requirement
2. competitive price in china market
3. mature technical support
4. professional logistic support
5. full experience of large numbers containers loading in chinese sea port
6. fast shipment by reputed shipping line
7. packing with pallet as buyer's special request
8. best service after shipment with email !
9. cargoes together with container after-sales service available
10. full experience in export
11. raw materials from chinese origin
Details
Quality information for Nilotinib intermediate/4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid CAS:641569-94-0
Name |
Nilotinib intermediate 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
CAS | 641569-94-0 |
MF | C17H14N4O2 |
Use for Nilotinib intermediate/4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid CAS:641569-94-0
It is used as the main intermediate of Nilotinib hcl.
Nilotinib hcl is used for the treatment of chronic myelogenous leukemia resistant to gleevec (imatinib).